Register entry

Dynavax Technologies Corporation

Data as of · How to read this entry

Registered sites
2
Active NDC listings
1
Live patents
0
Countries
2
Base
United States
Authorisation

Registered operations

Analytical testing2Active ingredient (API) manufacture1
Sites

Registered establishments

2
EstablishmentAddressRegistered forFEI / DUNS
Dynavax GmbHRegistrant: Dynavax Technologies CorporationEichsfelder Strasse 11, D�sseldorf, NW D-40595, Germany (DEU)Analytical testing, Active ingredient (API) manufacture3010165220318031242
Dynavax Technologies Corporation2100 Powell St., Suite 720, Emeryville, California (CA) 94608, United States (USA)Analytical testing3003212117964173801
Catalogue

Marketed products

1
BrandGeneric nameForm / routeNDC
HEPLISAV-BHepatitis B Vaccine (Recombinant) Adjuvantedinjection, solution, intramuscular43528-003BLA
Neighbours

Registered in the same town

1
Compare

Comparable companies in United States

Enquiry

Common questions

Is Dynavax Technologies Corporation FDA approved?
Dynavax Technologies Corporation holds 2 FDA-registered establishments across 2 countries. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Dynavax Technologies Corporation's drugs manufactured?
At registered sites in Germany, the United States. The FDA register lists D�sseldorf; Emeryville, CA. Registered operations: analytical testing, active ingredient (API) manufacture.
What drugs does Dynavax Technologies Corporation make?
1 product is listed under Dynavax Technologies Corporation in the openFDA NDC Directory, most often as injection, solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.